Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Journal of Pancreatology|March 6, 2020
Development of microRNA-based therapy for pancreatic cancerAndrew Fesler, Jingfang JuCell Cycle (Georgetown, Tex.)|December 21, 2012
MicroRNA: a third dimension in autophagyHaiyan Zhai, Andrew Fesler, Jingfang JuOncotargets and Therapy|September 5, 2014
miR-129 as a novel therapeutic target and biomarker in gastrointestinal cancerAndrew Fesler, Haiyan Zhai, Jingfang JuF1000Research|August 11, 2016
The expanding regulatory universe of p53 in gastrointestinal cancerAndrew Fesler, Ning Zhang, Jingfang JuOncotarget|February 9, 2018
Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1Andrew Fesler, Hua Liu, Jingfang JuCancer Translational Medicine|October 18, 2016
Implications of Circadian Rhythm Regulation by microRNAs in Colorectal CancerSong Wu, Andrew Fesler, Jingfang JuMolecular Diagnosis & Therapy|February 26, 2014
Circulating microRNA testing for the early diagnosis and follow-up of colorectal cancer patientsAndrew Fesler, Jingting Jiang, Haiyan Zhai, et al.Biomarker Research|June 27, 2018
microRNA based prognostic biomarkers in pancreatic CancerShixiang Guo, Andrew Fesler, Huaizhi Wang, et al.Oncotarget|March 7, 2018
Development of novel miR-129 mimics with enhanced efficacy to eliminate chemoresistant colon cancer stem cellsNing Wu, Andrew Fesler, Hua Liu, et al.Epigenomics|May 19, 2017
Overcoming chemoresistance in cancer stem cells with the help of microRNAs in colorectal cancerAndrew Fesler, Shixiang Guo, Hua Liu, et al.Pageof 3